Older adults taking antihyperglycemics are inherently at a higher risk for hypoglycemia but studies suggest that many patients with complex medical problems and in poor health are being overtreated.
Read More
Type 2 diabetes (type 2 DM) is a progressive disease. Even with substantial advances in treatment, glycemic control remains elusive, and most patients require combination therapy.
Read More
With new, improved, but costly alternatives available, it’s going to be challenging for ambulatory care practitioners to evaluate if the potential benefits of using these newer medication classes as first-line therapy (instead of metformin) outweigh their big price tag.
Read More
Fasting is an important component of Ramadan for Muslims. A majority of patients with diabetes choose to fast. Pharmacists can play a vital role in helping patients to safely fast.
Read More
Every year, clinicians eagerly read, discuss, and apply the Standards of Medical Care for Diabetes published in the January issue of Diabetes Care.
Read More
About 1 in 3 patients diagnosed with diabetes have comorbid CKD. While several treatments are available to halt the progression of CKD, more are needed.
Read More
While the glucagon-like peptide-1 (GLP-1) receptor agonists improve glycemic control, renal, and cardiovascular outcomes and induce significant weight loss, drugs that target more than one incretin hormone may have even greater therapeutic benefits.
Read More
Insulin is the preferred agent for the management of type 2 diabetes mellitus during pregnancy. However, metformin may have several advantages. Perhaps a combination would be even better?
Read More
iForumRx.org is a web-based community of practice designed to inform ambulatory care pharmacy specialists, pharmacy residents, and student pharmacists about high-quality, practice-changing evidence.
Loading ...